A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.
An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
Distinguishing people who don't have illness from those who already have ongoing illness will enable personalized approaches ...
Over 75 medical organisations worldwide have endorsed the new definitions, reflecting a growing consensus for reform.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties.
The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.